糖尿病是一种慢性消耗性内分泌代谢性疾病,它是由于人体β细胞分泌胰岛素相对不足,从而导致心、脑、肾及眼神经等组织器官的慢性病变。目前,对糖尿病的治疗偏重于西药,短期疗效尚可,但长期服用会导致药物的依赖性和毒副作用,久之,加速胰岛细胞的老化诱发多种并发症。亚太中国区糖尿病控制中心、中国中医疑难病高血糖研究总院是国家指定担任糖尿病攻关的权威科研机构,聚集了国内外数百位博士生导师、生物基因免疫学、遗传学、中医学专家经十多年的研究和探索,采用中医理论之精华与生物基因相结合,精选几十种名贵中药和生物活性酶,经高科技浓缩提炼科学配伍,成功地研制出新一代治疗糖尿病的 Diabetes is a chronic consuming endocrine and metabolic disease, it is due to the relative lack of insulin secretion of human β cells, leading to chronic lesions of tissues and organs such as heart, brain, kidney and oculomotor nerves. At present, the treatment of diabetes is more emphasis on Western medicine, short-term effect is acceptable, but long-term use will lead to drug dependence and side effects, a long time to accelerate the aging of islet cells induced a variety of complications. Asia-Pacific China Diabetes Control Center, China Institute of Traditional Chinese Medicine Difficult and Hyperglycemia Research Institute is designated as the authority of research institutions for diabetes research, gathering hundreds of doctoral tutor at home and abroad, biological genetics, genetics, Chinese medicine experts More than 10 years of research and exploration, using the essence of Chinese medicine theory and biological genes combined with the selection of dozens of precious Chinese medicine and bio-active enzymes, refined by high-tech refining scientific compatibility, successfully developed a new generation of diabetes treatment